Biohaven Ltd
For the period ended Jun 30, 2024. Filed Aug 9, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 9, 2024
BHVN$14.48+4.2%Stored close · as of Nov 6, 2026
Contents
Item 1. Condensed Consolidated Balance Sheets
CONDENSED CONSOLIDATED BALANCE SHEETS
(Amounts in thousands, except share amounts)
| June 30, 2024 | December 31, 2023 | |
|---|---|---|
| (Unaudited) | ||
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $239,147 | $248,402 |
| Marketable securities | 197,801 | 133,417 |
| Prepaid expenses | 59,532 | 35,242 |
| Income tax receivable | 7,522 | 13,252 |
| Other current assets | 7,266 | 12,133 |
| Total current assets | 511,268 | 442,446 |
| Property and equipment, net | 18,665 | 17,191 |
| Intangible assets | 18,400 | 18,400 |
| Goodwill | 1,390 | 1,390 |
| Other non-current assets | 32,918 | 33,785 |
| Total assets | $582,641 | $513,212 |
| Liabilities and Shareholders' Equity | ||
| Current liabilities: | ||
| Accounts payable | $17,259 | $15,577 |
| Accrued expenses and other current liabilities | 57,728 | 39,846 |
| Forward contract and derivative liabilities | 81,220 | — |
| Total current liabilities | 156,207 | 55,423 |
| Non-current operating lease liabilities | 26,193 | 27,569 |
| Derivative liability, non-current | 12,180 | — |
| Other non-current liabilities | 4,321 | 2,245 |
| Total liabilities | 198,901 | 85,237 |
| Commitments and contingencies (Note 11) | ||
| Shareholders' Equity: | ||
| Preferred shares, no par value; 10,000,000 shares authorized, no shares issued and outstanding as of June 30, 2024 and December 31, 2023 | — | — |
| Common shares, no par value; 200,000,000 shares authorized as of June 30, 2024 and December 31, 2023; 92,346,332 and 81,115,723 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively | 1,298,553 | 887,528 |
| Additional paid-in capital | 83,832 | 39,804 |
| Accumulated deficit | (998,567) | (499,292) |
| Accumulated other comprehensive loss | (78) | (65) |
| Total shareholders' equity | 383,740 | 427,975 |
| Total liabilities and shareholders' equity | $582,641 | $513,212 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.